{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,20]],"date-time":"2026-10-20T15:58:19Z","timestamp":1792511899385,"version":"4.5.0"},"reference-count":37,"publisher":"Association for Research in Vision and Ophthalmology (ARVO)","issue":"9","license":[{"start":{"date-parts":[[2020,8,5]],"date-time":"2020-08-05T00:00:00Z","timestamp":1596585600000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Trans. Vis. Sci. Tech."],"published-print":{"date-parts":[[2020,8,5]]},"DOI":"10.1167\/tvst.9.9.7","type":"journal-article","created":{"date-parts":[[2020,8,5]],"date-time":"2020-08-05T11:32:01Z","timestamp":1596627121000},"page":"7","source":"Crossref","is-referenced-by-count":10,"title":["DS-7080a, a Selective Anti-ROBO4 Antibody, Shows Anti-Angiogenic Efficacy with Distinctly Different Profiles from Anti-VEGF Agents"],"prefix":"10.1167","volume":"9","author":[{"given":"Yoshitaka","family":"Isumi","sequence":"first","affiliation":[{"name":"Oncology Research Laboratories I, Oncology Function, R&D Division, Daiichi Sankyo Co., Ltd., Tokyo, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shinko","family":"Hayashi","sequence":"additional","affiliation":[{"name":"Oncology Research Laboratories I, Oncology Function, R&D Division, Daiichi Sankyo Co., Ltd., Tokyo, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tatsuya","family":"Inoue","sequence":"additional","affiliation":[{"name":"Specialty Medicine Research Laboratories I, Research Function, R&D Division, Daiichi Sankyo Co., Ltd., Tokyo, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yasushi","family":"Yoshigae","sequence":"additional","affiliation":[{"name":"Research Planning Group, Research Function, R&D Division, Daiichi Sankyo Co., Ltd., Tokyo, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Toshiyuki","family":"Sato","sequence":"additional","affiliation":[{"name":"Specialty Medicine Research Laboratories II, Research Function, R&D Division, Daiichi Sankyo Co., Ltd., Tokyo, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jun","family":"Hasegawa","sequence":"additional","affiliation":[{"name":"Modality Research Laboratories, Biologics Division, Daiichi Sankyo Co., Ltd., Tokyo, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Toshinori","family":"Agatsuma","sequence":"additional","affiliation":[{"name":"Oncology Research Laboratories I, Oncology Function, R&D Division, Daiichi Sankyo Co., Ltd., Tokyo, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"27","reference":[{"key":"bib1","doi-asserted-by":"publisher","first-page":"2057","DOI":"10.1001\/jama.290.15.2057","article-title":"Important causes of visual impairment in the world today","volume":"290","author":"Congdon","year":"2003","journal-title":"JAMA"},{"key":"bib2","doi-asserted-by":"publisher","first-page":"151","DOI":"10.1002\/path.4266","article-title":"Mechanisms of age-related macular degeneration and therapeutic opportunities","volume":"232","author":"van Lookeren Campagne","year":"2014","journal-title":"J Pathol"},{"key":"bib3","doi-asserted-by":"publisher","first-page":"1728","DOI":"10.1016\/S0140-6736(12)60282-7","article-title":"Age-related macular degeneration","volume":"379","author":"Lim","year":"2012","journal-title":"Lancet"},{"key":"bib4","doi-asserted-by":"publisher","first-page":"1419","DOI":"10.1056\/NEJMoa054481","article-title":"Ranibizumab for neovascular age-related macular degeneration","volume":"355","author":"Rosenfeld","year":"2006","journal-title":"N Engl J Med"},{"key":"bib5","doi-asserted-by":"publisher","first-page":"1432","DOI":"10.1056\/NEJMoa062655","article-title":"Ranibizumab versus verteporfin for neovascular age-related macular degeneration","volume":"355","author":"Brown","year":"2006","journal-title":"N Engl J Med"},{"key":"bib6","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1016\/j.ophtha.2008.10.018","article-title":"Ranibizumab versus verteporfin photodynamic therapy for neovascular age-related macular degeneration: two-year results of the ANCHOR Study","volume":"116","author":"Brown","year":"2009","journal-title":"Ophthalmology"},{"key":"bib7","doi-asserted-by":"publisher","first-page":"2537","DOI":"10.1016\/j.ophtha.2012.09.006","article-title":"Intravitreal aflibercept (VEGF trap-eye) in wet age-related macular degeneration","volume":"119","author":"Heier","year":"2012","journal-title":"Ophthalmology"},{"key":"bib8","doi-asserted-by":"publisher","first-page":"571","DOI":"10.1016\/j.ophtha.2014.09.024","article-title":"Improvement in vision-related function with intravitreal aflibercept: data from phase 3 studies in wet age-related macular degeneration","volume":"122","author":"Yuzawa","year":"2015","journal-title":"Ophthalmology"},{"key":"bib9","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1586\/eop.09.67","article-title":"Neovascular age-related macular degeneration and anti-VEGF nonresponders","volume":"5","author":"Sheybani","year":"2010","journal-title":"Exp Rev Ophthalmol"},{"key":"bib10","doi-asserted-by":"publisher","first-page":"1631","DOI":"10.1136\/bjo.2010.186361","article-title":"Cytokines in neovascular age-related macular degeneration: fundamentals of targeted combination therapy","volume":"95","author":"de Oliveira Dias","year":"2011","journal-title":"Br J Ophthalmol"},{"key":"bib11","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1186\/s40942-017-0084-9","article-title":"Retinal and choroidal angiogenesis: a review of new targets","volume":"3","author":"Cabral","year":"2017","journal-title":"Int J Retina Vitreous"},{"key":"bib12","doi-asserted-by":"publisher","first-page":"205","DOI":"10.1016\/S0092-8674(00)80915-0","article-title":"Roundabout controls axon crossing of the CNS midline and defines a novel subfamily of evolutionarily conserved guidance receptors","volume":"92","author":"Kidd","year":"1998","journal-title":"Cell"},{"key":"bib13","doi-asserted-by":"publisher","first-page":"547","DOI":"10.1006\/geno.2002.6745","article-title":"Magic roundabout is a new member of the roundabout receptor family that is endothelial specific and expressed at sites of active angiogenesis","volume":"79","author":"Huminiecki","year":"2002","journal-title":"Genomics"},{"key":"bib14","doi-asserted-by":"publisher","first-page":"251","DOI":"10.1016\/S0012-1606(03)00258-6","article-title":"Robo4 is a vascular-specific receptor that inhibits endothelial migration","volume":"261","author":"Park","year":"2003","journal-title":"Dev Biol"},{"key":"bib15","doi-asserted-by":"publisher","first-page":"448","DOI":"10.1038\/nm1742","article-title":"Robo4 stabilizes the vascular network by inhibiting pathologic angiogenesis and endothelial hyperpermeability","volume":"14","author":"Jones","year":"2008","journal-title":"Nat Med"},{"key":"bib16","doi-asserted-by":"publisher","first-page":"2804","DOI":"10.1182\/blood-2012-12-468363","article-title":"Robo4 is an effective tumor endothelial marker for antibody-drug conjugates based on the rapid isolation of the anti-Robo4 cell-internalizing antibody","volume":"121","author":"Yoshikawa","year":"2013","journal-title":"Blood"},{"key":"bib17","doi-asserted-by":"publisher","first-page":"272","DOI":"10.1016\/j.molonc.2015.10.007","article-title":"Endothelial Robo4 suppresses breast cancer growth and metastasis through regulation of tumor angiogenesis","volume":"10","author":"Zhao","year":"2016","journal-title":"Mol Oncol"},{"key":"bib18","doi-asserted-by":"publisher","first-page":"13517","DOI":"10.1038\/ncomms13517","article-title":"The Robo4 cytoplasmic domain is dispensable for vascular permeability and neovascularization","volume":"7","author":"Zhang","year":"2016","journal-title":"Nat Commun"},{"key":"bib19","doi-asserted-by":"publisher","first-page":"1325","DOI":"10.1038\/ncb1976","article-title":"Slit2\u2013Robo4 signalling promotes vascular stability by blocking Arf6 activity","volume":"11","author":"Jones","year":"2009","journal-title":"Nat Cell Biol"},{"key":"bib20","doi-asserted-by":"publisher","first-page":"23ra19","DOI":"10.1126\/scitranslmed.3000678","article-title":"Targeting Robo4-dependent Slit signaling to survive the cytokine storm in sepsis and influenza","volume":"2","author":"London","year":"2010","journal-title":"Sci Transl Med"},{"key":"bib21","doi-asserted-by":"publisher","first-page":"186","DOI":"10.1097\/MOH.0b013e328345a4b9","article-title":"Robo4-dependent Slit signaling stabilizes the vasculature during pathologic angiogenesis and cytokine storm","volume":"18","author":"London","year":"2011","journal-title":"Curr Opin Hematol"},{"key":"bib22","doi-asserted-by":"publisher","first-page":"385","DOI":"10.4049\/jimmunol.1302021","article-title":"Slit2-Robo4 pathway modulates lipopolysaccharide-induced endothelial inflammation and its expression is dysregulated during endotoxemia","volume":"192","author":"Zhao","year":"2014","journal-title":"J Immunol"},{"key":"bib23","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1016\/j.devcel.2010.12.001","article-title":"Robo4 maintains vessel integrity and inhibits angiogenesis by interacting with UNC5B","volume":"20","author":"Koch","year":"2011","journal-title":"Dev Cell"},{"key":"bib24","doi-asserted-by":"publisher","first-page":"2048","DOI":"10.1177\/0271678X18777916","article-title":"Annexin A2 is a Robo4 ligand that modulates ARF6 activation-associated cerebral trans-endothelial permeability","volume":"39","author":"Li","year":"2018","journal-title":"J Cereb Blood Flow Metab"},{"key":"bib25","doi-asserted-by":"publisher","first-page":"10029","DOI":"10.1073\/pnas.86.24.10029","article-title":"A humanized antibody that binds to the interleukin 2 receptor","volume":"86","author":"Queen","year":"1989","journal-title":"Proc Natl Acad Sci USA"},{"key":"bib26","doi-asserted-by":"publisher","first-page":"431","DOI":"10.1007\/BF00267823","article-title":"A single protocol to detect transcripts of various types and expression levels in neural tissue and cultured cells: in situ hybridization using digoxigenin-labelled cRNA probes","volume":"100","author":"Schaeren-Wiemers","year":"1993","journal-title":"Histochemistry"},{"key":"bib27","doi-asserted-by":"publisher","first-page":"1042","DOI":"10.1001\/archophthalmol.2011.210","article-title":"Prevention of experimental choroidal neovascularization and resolution of active lesions by VEGF trap in nonhuman primates","volume":"129","author":"Nork","year":"2011","journal-title":"Arch Ophthalmol"},{"key":"bib28","doi-asserted-by":"publisher","first-page":"252","DOI":"10.1016\/j.lungcan.2013.04.014","article-title":"Favorable prognosis of operable non-small cell lung cancer (NSCLC) patients harboring an increased expression of tumor endothelial markers (TEMs)","volume":"81","author":"Pircher","year":"2013","journal-title":"Lung Cancer"},{"key":"bib29","doi-asserted-by":"publisher","first-page":"161","DOI":"10.1007\/s11060-015-1780-7","article-title":"Overexpression of Roundabout4 predicts poor prognosis of primary glioma patients via correlating with microvessel density","volume":"123","author":"Cai","year":"2015","journal-title":"J Neurooncol"},{"key":"bib30","doi-asserted-by":"publisher","first-page":"28","DOI":"10.18632\/aging.v2i1","article-title":"Attainment of polarity promotes growth factor secretion by retinal pigment epithelial cells: relevance to age-related macular degeneration","volume":"2","author":"Sonoda","year":"2009","journal-title":"Aging"},{"key":"bib31","doi-asserted-by":"publisher","first-page":"767","DOI":"10.1007\/s00417-009-1058-x","article-title":"Combinatory inhibition of VEGF and FGF2 is superior to solitary VEGF inhibition in an in vitro model of RPE-induced angiogenesis","volume":"247","author":"Stahl","year":"2009","journal-title":"Graefes Arch Clin Exp Ophthalmol"},{"key":"bib32","doi-asserted-by":"publisher","first-page":"26","DOI":"10.1016\/j.neuron.2012.06.018","article-title":"Mechanisms of age-related macular degeneration","volume":"75","author":"Ambati","year":"2012","journal-title":"Neuron"},{"key":"bib33","doi-asserted-by":"publisher","first-page":"859","DOI":"10.3928\/23258160-20170928-14","article-title":"The impact of switching anti-vascular endothelial growth factor therapy in the management of exudative age-related macular degeneration","volume":"48","author":"Chia","year":"2017","journal-title":"Ophthalmic Surg Lasers Imaging Retina"},{"key":"bib34","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1136\/bjo.2011.203893","article-title":"Tachyphylaxis during treatment of exudative age-related macular degeneration with ranibizumab","volume":"96","author":"Eghoj","year":"2012","journal-title":"Br J Ophthalmol"},{"key":"bib35","doi-asserted-by":"publisher","first-page":"79","DOI":"10.1016\/j.exer.2008.10.014","article-title":"Differences in the temporal expression of regulatory growth factors during choroidal neovascular development","volume":"88","author":"Hu","year":"2009","journal-title":"Exp Eye Res"},{"key":"bib36","doi-asserted-by":"publisher","first-page":"128","DOI":"10.3109\/02713683.2012.738844","article-title":"Effect of Robo4 on retinal endothelial permeability","volume":"38","author":"Cheng","year":"2013","journal-title":"Curr Eye Res"},{"key":"bib37","doi-asserted-by":"publisher","first-page":"171","DOI":"10.1007\/s10456-011-9249-6","article-title":"Binding and neutralization of vascular endothelial growth factor (VEGF) and related ligands by VEGF Trap, ranibizumab and bevacizumab","volume":"15","author":"Papadopoulos","year":"2012","journal-title":"Angiogenesis"}],"container-title":["Translational Vision Science & Technology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/tvst.arvojournals.org\/article.aspx?articleid=2770583","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,8,5]],"date-time":"2020-08-05T11:32:04Z","timestamp":1596627124000},"score":1,"resource":{"primary":{"URL":"https:\/\/tvst.arvojournals.org\/article.aspx?articleid=2770583"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,8,5]]},"references-count":37,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2020,8,3]]}},"URL":"https:\/\/doi.org\/10.1167\/tvst.9.9.7","relation":{},"ISSN":["2164-2591"],"issn-type":[{"value":"2164-2591","type":"print"}],"subject":[],"published":{"date-parts":[[2020,8,5]]}}}